Earnings Per Share, Basic of Liminatus Pharma, Inc. from 31 Mar 2024 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Liminatus Pharma, Inc. quarterly Earnings Per Share, Basic in USD/shares history and change rate from 31 Mar 2024 to 30 Sep 2025.
  • Liminatus Pharma, Inc. Earnings Per Share, Basic for the quarter ending 30 Sep 2025 was -0.07, a 133% decline year-over-year.
Source SEC data
View on sec.gov
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)

Liminatus Pharma, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 -0.07 -0.04 -133% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 0 +0.05 01 Apr 2025 30 Jun 2025 10-Q 06 Oct 2025 2025 Q2
Q1 2025 -2.55 -0.08 -3.2% 01 Jan 2025 31 Mar 2025 10-Q 02 Jun 2025 2025 Q1
Q3 2024 -0.03 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 -0.05 01 Apr 2024 30 Jun 2024 10-Q 06 Oct 2025 2025 Q2
Q1 2024 -2.47 01 Jan 2024 31 Mar 2024 10-Q 02 Jun 2025 2025 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.